Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
British Journal of Clinical Pharmacology|July 27, 2010
Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patientsKimie Sai, Yoshiro Saito, Naoko Tatewaki, et al.
Drug Metabolism and Pharmacokinetics|August 17, 2011
Genetic variation and haplotype structures of the glutathione S-transferase genes GSTA1 and GSTA2 in Japanese colorectal cancer patientsKeiko Maekawa, Tetsuya Hamaguchi, Yoshiro Saito, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Three novel single nucleotide polymorphisms in UGT1A10Mayumi Saeki, Shogo Ozawa, Yoshiro Saito, et al.
Cancer Science|January 19, 2019
Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancerTadamichi Denda, Daisuke Sakai, Tetsuya Hamaguchi, et al.
Japanese Journal of Clinical Oncology|August 30, 2024
Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study groupAtsuo Takashima, Megumi Ishiguro, Keita Sasaki, et al.
Drug Metabolism and Pharmacokinetics|May 1, 2008
Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese populationKimie Sai, Yoshiro Saito, Masaya Itoda, et al.
Cancer Science|July 6, 2025
ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction CancerAkihito Kawazoe, Kensei Yamaguchi, Tetsuya Hamaguchi, et al.
Journal of Cancer Survivorship : Research and Practice|December 8, 2019
Developing the structure of Japan's cancer survivorship guidelines using an expert panel and modified Delphi methodYutaka J Matsuoka, Ryo Okubo, Yoichi Shimizu, et al.
Pageof 22